Standard Biotools Inc (LAB) insider trading
Every open-market stock purchase and sale by Standard Biotools Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $14.4M over the last 12 months (5 buys).
- Last insider buy: Casdin Partners Master Fund L.P. (10% owner), $217K, 11 months ago.
Last 12 months: insiders bought $14.4M (5 buys) and sold $0 (0 sales). Last close $0.65 on Oct 21, 2026.
Recent LAB insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 20, 2026 | Michael Egholm (CEO) | Sold (not open market) | $65.6K |
| Aug 20, 2026 | Hanjoon Alex Kim (CFO) | Sold (not open market) | $18.9K |
| Aug 20, 2026 | Sean Mackay (C-suite exec) | Sold (not open market) | $17.3K |
| Aug 3, 2026 | Michael Egholm (CEO) | Sold (not open market) | $315K |
| Jul 23, 2026 | Hanjoon Alex Kim (CFO) | Sold (not open market) | $181K |
| Jun 20, 2026 | Sean Mackay (C-suite exec) | Bought (not open market) | — |
| Jun 18, 2026 | Troy Cox (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Fenel M Eloi (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Fenel M Eloi (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Kathy L Hibbs (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Kathy L Hibbs (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Frank Witney (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Frank Witney (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Thomas D. Carey (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Thomas D. Carey (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Eli Casdin (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Eli Casdin (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Troy Cox (Insider) | Bought (not open market) | — |
| May 20, 2026 | Michael Egholm (CEO) | Sold (not open market) | $97.6K |
| May 20, 2026 | Sean Mackay (C-suite exec) | Sold (not open market) | $25.7K |
| May 20, 2026 | Hanjoon Alex Kim (CFO) | Sold (not open market) | $18.9K |
| Apr 6, 2026 | Michael Egholm (CEO) | Sold (not open market) | $86.3K |
| Apr 6, 2026 | Hanjoon Alex Kim (CFO) | Sold (not open market) | $19.3K |
| Apr 6, 2026 | Michael Egholm (CEO) | Bought (not open market) | — |
| Apr 6, 2026 | Hanjoon Alex Kim (CFO) | Bought (not open market) | — |
Who's trading LAB
- Michael Egholm, CEO: other filings, last Aug 20, 2026
- Sean Mackay, C-suite exec: other filings, last Aug 20, 2026
- Hanjoon Alex Kim, CFO: other filings, last Aug 20, 2026
- Troy Cox, Director: other filings, last Jun 18, 2026
- Fenel M Eloi, Insider: other filings, last Jun 18, 2026
- Kathy L Hibbs, Insider: other filings, last Jun 18, 2026
- Frank Witney, Insider: other filings, last Jun 18, 2026
- Thomas D. Carey, Insider: other filings, last Jun 18, 2026
- Eli Casdin, Insider: other filings, last Jun 18, 2026
- Casdin Partners Master Fund L.P., 10% owner: bought $14.4M (15 buys), last Dec 4, 2025
Get free alerts when an insider at Standard Biotools Inc files a new trade →